HCSGD entry for PTPN11
1. General information
Official gene symbol | PTPN11 |
---|---|
Entrez ID | 5781 |
Gene full name | protein tyrosine phosphatase, non-receptor type 11 |
Other gene symbols | BPTP3 CFC NS1 PTP-1D PTP2C SH-PTP2 SH-PTP3 SHP2 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000077 | DNA damage checkpoint | IEA | biological_process |
GO:0000187 | Activation of MAPK activity | IEA | biological_process |
GO:0004721 | Phosphoprotein phosphatase activity | IDA | molecular_function |
GO:0004725 | Protein tyrosine phosphatase activity | IDA TAS | molecular_function |
GO:0004726 | Non-membrane spanning protein tyrosine phosphatase activity | IMP TAS | molecular_function |
GO:0005070 | SH3/SH2 adaptor activity | IDA | molecular_function |
GO:0005158 | Insulin receptor binding | IPI | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0005739 | Mitochondrion | IEA | cellular_component |
GO:0005829 | Cytosol | TAS | cellular_component |
GO:0006641 | Triglyceride metabolic process | IEA | biological_process |
GO:0007173 | Epidermal growth factor receptor signaling pathway | TAS | biological_process |
GO:0007411 | Axon guidance | TAS | biological_process |
GO:0007420 | Brain development | IMP | biological_process |
GO:0007507 | Heart development | IMP | biological_process |
GO:0007596 | Blood coagulation | TAS | biological_process |
GO:0008286 | Insulin receptor signaling pathway | TAS | biological_process |
GO:0008543 | Fibroblast growth factor receptor signaling pathway | TAS | biological_process |
GO:0009755 | Hormone-mediated signaling pathway | IEA | biological_process |
GO:0019221 | Cytokine-mediated signaling pathway | TAS | biological_process |
GO:0019904 | Protein domain specific binding | IEA | molecular_function |
GO:0030971 | Receptor tyrosine kinase binding | IEA | molecular_function |
GO:0031295 | T cell costimulation | TAS | biological_process |
GO:0031748 | D1 dopamine receptor binding | IEA | molecular_function |
GO:0033628 | Regulation of cell adhesion mediated by integrin | IMP | biological_process |
GO:0035265 | Organ growth | IEA | biological_process |
GO:0035335 | Peptidyl-tyrosine dephosphorylation | IDA IMP | biological_process |
GO:0036302 | Atrioventricular canal development | IMP | biological_process |
GO:0038095 | Fc-epsilon receptor signaling pathway | TAS | biological_process |
GO:0038127 | ERBB signaling pathway | IDA | biological_process |
GO:0040014 | Regulation of multicellular organism growth | IEA | biological_process |
GO:0042445 | Hormone metabolic process | IEA | biological_process |
GO:0042593 | Glucose homeostasis | IEA | biological_process |
GO:0043234 | Protein complex | IEA | cellular_component |
GO:0043274 | Phospholipase binding | IEA | molecular_function |
GO:0043560 | Insulin receptor substrate binding | IEA | molecular_function |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0046676 | Negative regulation of insulin secretion | IEA | biological_process |
GO:0046825 | Regulation of protein export from nucleus | IEA | biological_process |
GO:0046887 | Positive regulation of hormone secretion | IEA | biological_process |
GO:0048011 | Neurotrophin TRK receptor signaling pathway | TAS | biological_process |
GO:0048013 | Ephrin receptor signaling pathway | IDA | biological_process |
GO:0048015 | Phosphatidylinositol-mediated signaling | TAS | biological_process |
GO:0048609 | Multicellular organismal reproductive process | IEA | biological_process |
GO:0048806 | Genitalia development | IMP | biological_process |
GO:0048839 | Inner ear development | IMP | biological_process |
GO:0050900 | Leukocyte migration | TAS | biological_process |
GO:0051428 | Peptide hormone receptor binding | IEA | molecular_function |
GO:0051463 | Negative regulation of cortisol secretion | IEA | biological_process |
GO:0060125 | Negative regulation of growth hormone secretion | IEA | biological_process |
GO:0060325 | Face morphogenesis | IMP | biological_process |
GO:0060333 | Interferon-gamma-mediated signaling pathway | TAS | biological_process |
GO:0060334 | Regulation of interferon-gamma-mediated signaling pathway | TAS | biological_process |
GO:0060337 | Type I interferon signaling pathway | TAS | biological_process |
GO:0060338 | Regulation of type I interferon-mediated signaling pathway | TAS | biological_process |
GO:2001275 | Positive regulation of glucose import in response to insulin stimulus | IDA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0535658030 | 0.8101448615 | 0.5053483513 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0267651031 |
GSE13712_SHEAR | Up | 0.1030536396 |
GSE13712_STATIC | Up | 0.0147912821 |
GSE19018 | Down | -0.2025851822 |
GSE19899_A1 | Down | -0.0499550713 |
GSE19899_A2 | Up | 0.0571228304 |
PubMed_21979375_A1 | Down | -0.1155585082 |
PubMed_21979375_A2 | Down | -0.3242426699 |
GSE35957 | Up | 0.4812581529 |
GSE36640 | Up | 0.1803552248 |
GSE54402 | Up | 0.1732924104 |
GSE9593 | Up | 0.3936875083 |
GSE43922 | Down | -0.0053150529 |
GSE24585 | Down | -0.2239125975 |
GSE37065 | Down | -0.1929912679 |
GSE28863_A1 | Up | 0.8219538683 |
GSE28863_A2 | Up | 1.2345263211 |
GSE28863_A3 | Up | 0.4668827502 |
GSE28863_A4 | Up | 0.1356635849 |
GSE48662 | Up | 0.1397006815 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Dodecane-Trimethylamine | DB02779 | EXPT00833 |
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-181a-5p | MIMAT0000256 | MIRT006482 | Luciferase reporter assay//Western blot | Functional MTI | 17382377 |
hsa-miR-489-3p | MIMAT0002805 | MIRT003549 | Luciferase reporter assay//Western blot | Functional MTI | 20700123 |
hsa-miR-23a-3p | MIMAT0000078 | MIRT007150 | Luciferase reporter assay | Functional MTI | 23420868 |
hsa-miR-124-3p | MIMAT0000422 | MIRT022573 | Microarray | Functional MTI (Weak) | 18668037 |
hsa-miR-218-5p | MIMAT0000275 | MIRT024234 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-130b-5p | MIMAT0004680 | MIRT038301 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-193b-3p | MIMAT0002819 | MIRT041308 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-320a | MIMAT0000510 | MIRT044548 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-183-5p | MIMAT0000261 | MIRT047153 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 2 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
23897841 | Impairment of Jak-Stat3 activation caused by GADD45G expression was associated with activation of SH2 domain-containing protein tyrosine phosphatase-2 (Shp2) |
21934682 | An important downstream modulator of this signal cascade is SHP2 (Src homology domain-containing phosphatase 2) |
21934682 | METHODS: We examined the The Cancer Genome Atlas (TCGA) database for SHP2 mutations |
21934682 | We identified five siRNAs from two independent commercial sources that were reported by the vendor to be pre-optimised in their specificity of SHP2 silencing |
21934682 | RESULTS: TCGA data demonstrate SHP2 to be mutated in 2% of the glioblastoma multiforme's studied |
21934682 | We confirmed the biological significance by siRNA knockdown of SHP2 |
21934682 | All five siRNAs tested reduced SHP2 expression by 70-100% and reduced glioblastoma cell line growth by up to 80% |
21934682 | Profiling the established molecular targets of SHP2 (ERK1/2 and STAT3) confirmed specificity of these siRNAs |
21934682 | The loss of cell viability induced by SHP2 silencing could not be explained by a significant increase in apoptosis alone as demonstrated by terminal deoxyribonucleotidyl transferase-mediated nick-end labelling and propidium iodide staining |
21934682 | Propidium iodide staining also showed that SHP2 silencing increases the population of glioblastoma cells in the G1 phase of the cell cycle and reduces the population of such cells in the G2/M- and S-phase |
21934682 | Selective inhibitors of SHP2 are commercially available and may be considered as a strategy for glioblastoma therapy |
Entries Per Page
Displaying Page of